TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD
31.75
-1.160 -3.654%
Share volume: 9,906,552
Last Updated: 03-05-2026
Pharmaceutical Products/Pharmaceutical Preparations:
3.31%
PREVIOUS CLOSE
CHG
CHG%
$32.91
-1.16
-0.04%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-08-2024 | 07-31-2024 | 11-06-2024 | 02-05-2025 | 05-07-2025 | 07-30-2025 | 11-05-2025 | 02-03-2026 | |
| Assets | |||||||||
| Total Assets | 42.772 B | 41.339 B | 41.758 B | 39.326 B | 38.415 B | 40.131 B | 39.856 B | 40.748 B | |
| Current Assets | 12.297 B | 11.633 B | 12.314 B | 12.552 B | 11.528 B | 12.620 B | 12.736 B | 13.946 B | |
| Inventories | 3.949 B | 3.927 B | 3.959 B | 3.007 B | 3.247 B | 3.497 B | 3.323 B | 3.179 B | |
| Other Current Assets | 1.831 B | 1.613 B | 445.000 M | 409.000 M | 368.000 M | 472.000 M | 477.000 M | 539.000 M | |
| Short Term Investments | 1.831 B | 1.613 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Receivables | 3.456 B | 3.766 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current Cash | 2.991 B | 2.258 B | 3.319 B | 3.300 B | 1.697 B | 2.161 B | 2.203 B | 3.556 B | |
| Total Non-current Assets | 30.475 B | 29.706 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Property Plant Equipment | 5.618 B | 5.573 B | 5.672 B | 4.581 B | 4.631 B | 4.810 B | 4.820 B | 4.080 B | |
| Other Assets | 470.000 M | 434.000 M | 23.773 B | 22.193 B | 22.255 B | 22.700 B | 22.301 B | 22.722 B | |
| Intangible Assets | 5.056 B | 4.853 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 17.007 B | 16.488 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | |||||||||
| Total Liabilities and shareholders’ equity | 42.772 B | 41.339 B | 41.758 B | 39.326 B | 38.415 B | 40.131 B | 39.856 B | 40.748 B | |
| Total liabilities | 35.495 B | 34.980 B | 35.375 B | 33.606 B | 32.146 B | 33.297 B | 32.602 B | 32.834 B | |
| Total current liabilities | 13.792 B | 13.039 B | 13.797 B | 12.796 B | 11.157 B | 11.861 B | 11.491 B | 13.456 B | |
| Accounts Payable | 2.439 B | 2.366 B | 2.371 B | 2.203 B | 2.290 B | 2.498 B | 2.355 B | 2.531 B | |
| Other liabilities | 3.991 B | 4.356 B | 4.639 B | 4.324 B | 4.299 B | 4.234 B | 3.947 B | 4.096 B | |
| Current long term debt | 3.060 B | 2.094 B | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 16.584 B | 16.547 B | 16.400 B | 16.002 B | 16.230 B | 16.763 B | 16.766 B | 14.986 B | |
| Other liabilities | 3.991 B | 4.356 B | 4.639 B | 4.324 B | 4.299 B | 4.234 B | 3.947 B | 4.096 B | |
| Minority interest | 265.000 M | 204.000 M | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 7.278 B | 6.359 B | 6.065 B | 5.373 B | 6.262 B | 6.826 B | 7.250 B | 7.910 B | |
| Common stock | 1.123 B | 1.133 B | 27.918 B | 27.822 B | 28.023 B | 28.061 B | 28.096 B | 28.191 B | |
| Retained earnings | -13.673 B | -14.519 B | -14.956 B | -15.173 B | -14.958 B | -14.676 B | -14.243 B | -13.762 B |